COMP <GO>
TDC vs CLBT // OPERATING MARGIN
Teradata Corporation (NYSE) VS. Cellebrite DI Ltd. (NASDAQ) • 15-METRIC TALLY: TDC 6
— CLBT 6
▲ OPERATING MARGIN LEADER: CLBT
LAST: $34.60 (+0.76%) • MKT CAP: $3.22B
operating-margins
12.30%
LAST: $12.28 (+3.02%) • MKT CAP: $3.09B
operating-margins
14.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TDC VS. CLBT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TDC | CLBT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 59.40% | 84.20% | -24.80 | CLBT | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 85.00% | 14.60% | +70.40 | TDC | /roic <GO> |
| EV/EBITDA & P/E Valuation | 14.3x | 38.1x | -23.80 | TDC | /valuation <GO> |
| Free Cash Flow Yield | 8.89% | 5.19% | +3.70 | TDC | /fcf-yield <GO> |
| Operating Margin ACTIVE | 12.30% | 14.00% | -1.70 | CLBT | /operating-margins <GO> |
| Net Profit Margin | 7.80% | 16.50% | -8.70 | CLBT | /net-margins <GO> |
| Revenue Growth (YoY) | -5.00% | 18.60% | -23.60 | CLBT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.00 | 4.95 | -3.95 | CLBT | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 8/9 | -2.00 | CLBT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 67.2 | 58.1 | +9.04 | TDC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 23.1x | 33.1x | -10.00 | TDC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.22B | $3.09B | $131.3M | TDC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TDC REV | CLBT REV | TDC GROSS % | CLBT GROSS % | TDC FCF | CLBT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.66B | $475.7M | 59.4% | 84.2% | $286.0M | $160.3M |
| FY 2024 | $1.75B | $401.2M | 60.5% | 84.4% | $279.0M | $123.6M |
| FY 2023 | $1.83B | $325.1M | — | — | $375.0M | $102.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TDC // BETA —
CLBT // BETA —